22.02.2024 - Two “Compassionate Use” Expanded Access Programs (EAPs) provided access to treatment with CNM-Au8 to more than 250 people living with amyotrophic lateral sclerosis (ALS).A significant survival benefit (p=0.0001) was observed in EAP participants . Seite 1
05.10.2023 - Funding to Support Research and Expanded Access of Investigational Drug in ALSSALT LAKE CITY, Oct. 05, 2023 (GLOBE NEWSWIRE) - Clene Inc. (Nasdaq: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc. in collaboration with Columbia . Seite 1